AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,306 | -84.2% | 27,461 | -87.3% | 0.00% | – |
Q2 2023 | $197,835 | -8.4% | 216,213 | -42.2% | 0.00% | -100.0% |
Q4 2022 | $215,965 | +27.0% | 374,289 | -30.3% | 0.00% | 0.0% |
Q3 2022 | $170,000 | +126.7% | 537,361 | +151.6% | 0.00% | – |
Q2 2022 | $75,000 | -65.9% | 213,549 | +119.8% | 0.00% | – |
Q4 2021 | $220,000 | -89.6% | 97,174 | -84.5% | 0.00% | -100.0% |
Q1 2021 | $2,121,000 | +45.5% | 626,577 | +20.3% | 0.01% | +50.0% |
Q4 2020 | $1,458,000 | -72.4% | 520,843 | +33.7% | 0.00% | -84.6% |
Q2 2020 | $5,289,000 | +3426.0% | 389,443 | +1864.2% | 0.03% | +2500.0% |
Q1 2020 | $150,000 | +31.6% | 19,827 | +9.8% | 0.00% | – |
Q4 2019 | $114,000 | -83.3% | 18,050 | -78.4% | 0.00% | -100.0% |
Q1 2019 | $684,000 | -9.6% | 83,546 | -39.0% | 0.00% | -33.3% |
Q4 2018 | $757,000 | +118.8% | 136,855 | +249.7% | 0.00% | +200.0% |
Q3 2018 | $346,000 | +54.5% | 39,136 | +74.2% | 0.00% | 0.0% |
Q2 2018 | $224,000 | +2.3% | 22,464 | -2.3% | 0.00% | 0.0% |
Q1 2018 | $219,000 | -92.8% | 22,999 | -85.1% | 0.00% | -90.9% |
Q3 2017 | $3,035,000 | +440.0% | 154,293 | +294.8% | 0.01% | +450.0% |
Q2 2017 | $562,000 | – | 39,085 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
Anson Funds Management LP | 95,342 | $267,000 | 0.05% |